Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Cognitive Science

Ritalin research: This “smart drug” can impair or enhance your creativity depending on your brain chemistry

by Eric W. Dolan
November 14, 2023
in Cognitive Science, Psychopharmacology
(Photo credit: OpenAI's DALL·E)

(Photo credit: OpenAI's DALL·E)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

New research provides evidence that individual differences in dopamine levels in the brain’s putamen region can influence how methylphenidate, a widely used “smart drug,” affects our creative thinking processes. The findings, published in Neuropsychopharmacology, indicate that the use of methylphenidate can impair specific forms of creativity in those with low baseline dopamine levels.

Methylphenidate is a psychostimulant drug commonly used to treat conditions like attention deficit hyperactivity disorder (ADHD). It primarily works by increasing the transmission of neurotransmitters like dopamine and noradrenaline in the brain by blocking their transporters. Psychostimulants like methylphenidate are also sometimes used for cognitive enhancement by healthy individuals, including students, to improve focus and concentration. This study aimed to investigate the cognitive and neurochemical mechanisms underlying the effects of methylphenidate on creativity.

“My interest in the topic was piqued by the nuanced effects of psychoactive drug on different individuals,” said study author Ceyda Sayali, a postdoctoral fellow transitioning into faculty in February 2024 at Johns Hopkins University School of Medicine.

“While these drugs are often hailed for their cognitive-enhancing abilities, they are not without their drawbacks, which can vary from person to person. For instance, methylphenidate, commonly known as Ritalin, is prescribed for ADHD but is also used off-label by healthy individuals seeking cognitive improvement. Studies suggest that 4% to 16% of students use such drugs without a prescription for academic purposes. Consider a student who takes Ritalin while cramming for exams.”

“While it may sharpen focus for some, it can actually hinder performance for others, especially if their natural cognitive abilities are already well-suited to the task at hand. This ‘cognitive doping’ might not be the panacea it’s often thought to be, as these drugs are originally formulated to address specific deficits rather than to universally boost cognitive function.”

To conduct the study, the researchers recruited 90 healthy volunteers between the ages of 18 to 45. They used a double-blind, placebo-controlled, cross-over design, which means that each participant received methylphenidate, sulpiride, or a placebo on different occasions, and the order of drug administration was randomized. Sulpiride was examined alongside methylphenidate because they both impact dopamine levels in the brain.

To assess creativity, Sayali and her colleagues employed various tasks designed to measure both divergent and convergent thinking. Divergent thinking, the ability to produce multiple ideas, was evaluated using the Alternative Uses Task. Convergent thinking, the process of identifying the single best solution, was assessed using the Remote Associates Test. In addition, the participants completed the Alternate Names Task, which measured both divergent and convergent thinking by having participants generate new names for items in various categories.

In a separate session, participants underwent PET brain imaging to measure their baseline levels of dopamine synthesis capacity, particularly in the striatum. The striatum is a region located deep within the brain and is part of the basal ganglia, a group of structures that play essential roles in various motor and cognitive functions. The striatum is a key component of the brain’s reward system and is involved in regulating a wide range of functions, including movement, motivation, and decision-making.

The researchers found a significant interaction between methylphenidate and baseline dopamine synthesis capacity in the putamen region of the brain. Specifically, methylphenidate reduced response divergence (variability in types of responses generated) in participants with low baseline dopamine synthesis capacity but increased it in those with high baseline dopamine levels. This suggests that the effect of methylphenidate on creativity depended on individual differences in baseline dopamine synthesis capacity.

“From our study, it’s clear that the effects of psychoactive drugs like Ritalin are not one-size-fits-all,” Sayali told PsyPost. “Specifically, we found that performance on creative tasks—those requiring ‘out-of-the-box’ thinking—was actually impaired in healthy participants with low baseline dopamine synthesis capacity and enhanced in those with high dopamine synthesis capacity. Therefore, the notion of using these drugs as a form of ‘cognitive doping’ to universally enhance brainpower is flawed; the outcome will vary based on your unique brain chemistry and the nature of the task you’re undertaking.”

Interestingly, there were no significant effects of individual variation in dopamine synthesis capacity on creative thinking scores when participants were tested with a placebo, which suggests that the effects of dopamine on creativity may not be evident under normal conditions but may become apparent when the system is manipulated, as with methylphenidate.

“What surprised me was the lack of a direct link between baseline dopamine synthesis capacity and creative thinking in the absence of a psychoactive drug,” Sayali said. “Given the significant role that dopamine plays in the brain on cognitive functions, one might expect individuals with higher dopamine levels to naturally exhibit greater creativity.”

“However, our findings did not support this assumption. This could be due to our study not examining dopamine receptor availability, which may be a critical factor in this equation. It’s a reminder that the brain’s workings are incredibly complex, and it cautions against oversimplified assumptions regarding the influence of brain dopamine on cognitive functions.”

While this study offers valuable insights into the impact of medications on creativity, it is not without limitations. One significant limitation is that the effects of sulpiride did not surface as expected, potentially due to suboptimal dosing or timing of the creativity tasks.

“A significant caveat of our study involves the inclusion of sulpiride, a selective dopamine antagonist that specifically modulates brain activity in the striatum,” Sayali told PsyPost. “Methylphenidate, on the other hand is not selective to dopamine in the striatum but also modulates dopamine levels in the prefrontal cortex along with increasing norepinephrine levels. We used sulpiride alongside methylphenidate to further isolate the effect of striatal dopamine.”

“The lack of effect from sulpiride on creative task performance, whether alone or in relation to striatal dopamine synthesis capacity, raises questions about the specific neural mechanisms at play. Specifically, it suggests that the impact of methylphenidate on divergent creativity might be mediated by dopamine modulation in the prefrontal cortex rather than the striatum. This hypothesis remains untested in our study but could be explored in future pharmacological neuroimaging research to clarify the neural substrates of creativity.”

“We also have to consider that the reason we didn’t see any change in creativity with sulpiride might be because of when we tested for creativity after taking the drug,” Sayali explained. “It’s a bit like trying to time your coffee so that your energy peak hits right when you’re starting a brainstorming session. In our study, we asked participants to do creative tasks about 5 hours after they took sulpiride, but since this drug usually hits its highest level in the blood after about 3 hours, it’s possible that the drug wasn’t working at full strength during our creativity tests.”

The study, “Methylphenidate undermines or enhances divergent creativity depending on baseline dopamine synthesis capacity“, was authored by Ceyda Sayalı, Ruben van den Bosch, Jessica I Määttä, Lieke Hofmans, Danae Papadopetraki, Jan Booij, Robbert-Jan Verkes, Matthijs Baas, and Roshan Cools.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
These common sounds can impair your learning, according to new psychology research
Cognitive Science

These common sounds can impair your learning, according to new psychology research

July 4, 2025

Your brain’s ancient defense system might be sabotaging your test scores. New research suggests our "behavioral immune system," which makes us subconsciously alert to signs of illness, can be triggered by coughs and sniffles.

Read moreDetails
From fireflies to brain cells: Unraveling the complex web of synchrony in networks
Addiction

Understanding “neuronal ensembles” could revolutionize addiction treatment

July 3, 2025

The same brain system that rewards you for a delicious meal is hijacked by drugs like fentanyl. A behavioral neuroscientist explains how understanding the specific memories behind these rewards is the key to treating addiction without harming our essential survival instincts.

Read moreDetails
Scientists just uncovered a surprising illusion in how we remember time
Memory

Scientists just uncovered a surprising illusion in how we remember time

July 3, 2025

Our perception of time is more fragile than we think. Scientists have uncovered a powerful illusion where repeated exposure to information makes us misremember it as happening much further in the past, significantly distorting our mental timelines.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Peppermint tea boosts memory and attention—but why?
Cognitive Science

Peppermint tea boosts memory and attention—but why?

July 2, 2025

Can a cup of peppermint tea sharpen your mind? A new study suggests it can—but not in the way scientists expected. Improved memory and attention followed the tea, but increased brain blood flow wasn't the reason why.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Scientists reveal ChatGPT’s left-wing bias — and how to “jailbreak” it
Artificial Intelligence

ChatGPT and “cognitive debt”: New study suggests AI might be hurting your brain’s ability to think

July 1, 2025

Researchers at MIT investigated how writing with ChatGPT affects brain activity and recall. Their findings indicate that reliance on AI may lead to reduced mental engagement, prompting concerns about cognitive “offloading” and its implications for education.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Breakfast habits are associated with depressive symptoms, study finds

Neuroscientists detect decodable imagery signals in brains of people with aphantasia

Loneliness predicts an increase in TV viewing for older women, but not for men

Othello syndrome: Woman’s rare stroke leads to psychotic delusions of infidelity

How to protect your mental health from a passive-aggressive narcissist

Dark personality traits linked to generative AI use among art students

Scientists are uncovering more and more unsettling facts about our politics

People with depression face significantly greater social and health-related challenges

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy